Plenary Session 2

Title Hypes and hopes of the artficial pancreas
Creators Thierry Berney
Peter Senior
Pierre-Yves Benhamou
Lectures Current automated insulin delivery systems : what do they really achieve ?
Patient-driven R&D : why-how-what ?
What will it take to address uncontrolled diabetes with closed-loop technology ?
Risk-benefit assessment of beta-cell replacement vs automated insulin delivery systems
Why you should attend As automated insulin delivery (AID) devices are about to hit the market, it is timely to review what they are actually able to achieve and how they compare with current biological beta cell replacement therapies.
What you will learn What is the current state-of-the-art in automated insulin delivery systems
What are the technological issues to solve or improve
How does AID benchmark against beta-cell replacement therapies
Persistance-webSoft
congresoft.fr
plateforme dédiée aux manifestations
Tel. : 01 84 17 20 55 / 06 89 19 34 06
E-mail : contact@congresoft.fr
La première plateforme Française de gestion de manifestations regroupant la billeterie, la gestion des hébergements, une boutique en ligne, la gestion des surfaces d'exposition et la gestion complète du programme scientifique.
Organisation de Congrès, manifestations, Séminiaires, Colloques